A startup focused on brain drugs officially launched Thursday, backed by $94 million from...

Today, a brief rundown of news involving Neumora Therapeutics and Pliant Therapeutics, as well...

Dive Brief: Aardvark Therapeutics on Wednesday night raised $94.2 million in an initial public...

A federal judge on Tuesday ordered the Food and Drug Administration and other federal...

Novartis is wagering more than $3 billion that a startup it helped launch six...

Today, a brief rundown of news involving Merck KGaA and BridgeBio Pharma, as well...

Stuart Arbuckle, Vertex’s chief operating officer and one of the company’s longest-tenured leaders, will...

Dive Brief: The Food and Drug Administration on Friday approved a new combination antibiotic...

Antibody-drug conjugates (ADCs) have emerged as one of the most promising advancements in precision...

Listen to the article 4 min This audio is auto-generated. Please let us know...

Sales of Cobenfy, a new mind-stabilizing medicine, totaled $10 million in the final months...

Dive Brief: Eli Lilly’s profit doubled in the fourth quarter as the Indianapolis-based drugmaker...

Dive Brief: Alumis and Acelyrin are merging, the biotechnology companies said Thursday afternoon, in...

Today, a brief rundown of news involving Mitsubishi Tanabe Pharma and Bausch + Lomb,...

Sionna Therapeutics on Thursday raised $191 million in an initial public offering that will...

Dive Brief: Bristol Myers Squibb is expanding its plan to cut costs, announcing alongside...

Dive Brief: Novo Nordisk is planning a new Phase 3 trial of its next-generation...

Dive Brief: Sales of both GSK’s and Pfizer’s vaccines for respiratory syncytial virus dropped...

Dive Brief: Omega Therapeutics, a genetic medicines maker originally backed by Flagship Pioneering, plans...

Listen to the article 3 min This audio is auto-generated. Please let us know...

Dive Brief: Adding Pfizer’s cancer drug Braftovi to standard treatments helped people with a...

In a little more than a week’s time, a drug developed by a small...

The role of China in the pharma market is changing. Until recently Chinese firms...

Dive Brief: 23andMe said Tuesday it is exploring “strategic alternatives,” which could include the...

Takeda CEO Christophe Weber plans to retire next year after a decade steering the...

Robert F. Kennedy Jr., President Donald Trump’s health secretary nominee, showed limited knowledge about...

Today, a brief rundown of news involving Novartis and AbbVie, as well as updates...

For the last quarter century, one of the world’s most capable drug developers toiled...

Metsera and Maze Therapeutics are the second and third biotechnology firms this year to...

The movement to steer pain treatment away from opioids notched a major victory Thursday,...

Robert F. Kennedy Jr. on Wednesday told U.S. lawmakers that, if confirmed as the...

Democratic senators confronted Robert F. Kennedy Jr. on his positions concerning vaccines, health services...

Dive Brief: A radiopharmaceutical medicine developed by Germany’s ITM outperformed everolimus, an older chemotherapy,...

Multiple lawmakers in Congress reported Tuesday that states were shut out of Medicaid payment...

Days into the Trump administration, several webpages covering diversity in clinical trials, annual medical...

Dive Brief: Sage Therapeutics’ board of directors has turned back partner Biogen’s opportunitistic attempt...

Cell & gene therapy stands at the forefront of modern medicine, promising transformative treatments...

Artificial intelligence was a topic of focus for the medical device industry in 2024. ...

Today, a brief rundown of news involving Merck & Co. and AstraZeneca, as well...

As the first major drug industry conference each year, the J.P. Morgan Healthcare Conference...

Dive Brief: An experimental obesity drug from Novo Nordisk helped people lose an average...

Sara Brenner, a Food and Drug Administration official within the agency’s medical device division,...

Dive Brief: Ascentage Pharma, a cancer drug developer based in Suzhou, China, on Thursday...

Prominent vaccine skeptic Robert F. Kennedy Jr. will testify before the Senate Finance Committee...

Dive Brief: Johnson & Johnson on Wednesday reported modestly higher-than-expected earnings for the fourth...

Johnson & Johnson expects changes in Medicare’s prescription drug benefit will negatively impact its...

Moderna will receive some $590 million from the U.S. government to develop messenger RNA...

Dive Brief: The Food and Drug Administration on Friday approved AstraZeneca and Daiichi Sankyo’s...

Dive Brief: The Food and Drug Administration needs stricter standards for the accelerated approval...

SAN FRANCISCO — With the close of J.P. Morgan Healthcare Conference, attention turns to...

Dive Brief: Eli Lilly won Food and Drug Administration approval to sell its Omvoh...

Semaglutide, the popular drug sold by Novo Nordisk as Ozempic for diabetes and Wegovy...

Today, a brief rundown of news involving Novo Nordisk and AstraZeneca, as well as...

Medicare’s next drug price negotiations will treat Novo Nordisk’s semaglutide as a single product,...

Roche has a big problem. With competition threatening some of its older and most...

Soon after starting a new biotechnology company, David Li realized he needed to rethink...

This week, the J.P. Morgan Healthcare Conference has brought a torrent of updates from...

On Tuesday morning, Biogen hosted an event for Wall Street analysts to better understand...

For any hopes the dealmaking that started the J.P. Morgan Healthcare Conference would give...

Dive Brief: Eli Lilly on Tuesday said the company’s revenue in 2024 totaled about...

Every January, the Westin St. Francis in San Francisco is, for a few days,...

Late last week, Biogen made an unsolicited offer to buy one of its partners,...

Genetic medicine startup Tune Therapeutics has raised another $175 million to develop therapies capable...

Dive Brief: An experimental menopause drug from Bayer succeeded in a late-stage trial in...

Dive Brief: Ouro Medicines, a new biotechnology startup, launched Friday with $120 million in...

Dive Brief: Intellia Therapeutics will stop work on one of its principal drug research...

Patrizia Cavazzoni, an influential Food and Drug Administration official who oversees much of the...

Today, a brief rundown of news involving Pfizer, AbbVie and Royalty Pharma, as well...

IGM Biosciences will scrap its top two drugs and lay off nearly three-quarters of...

Typically, the election of a Republican to the White House is welcome news for...

Maze Therapeutics on Tuesday filed plans for an initial public offering that could become...

GSK’s and Pfizer’s vaccines for respiratory syncytial virus must carry labels warning of a...

Dive Brief: Privately-held biotechnology startup Metsera said Tuesday a long-acting GLP-1 shot it’s developing...

Dive Brief: Vertex Pharmaceuticals will work together with Orna Therapeutics over the next three...

About four years ago, Sheldon Koenig was thinking about retiring. After spending decades in...

Dive Brief: Orbis Medicines, a European biotechnology startup, has raised 90 million euros, or...

Incretin drugs have been so successful in clinical testing they’re akin to a pharmaceutical...

The Food and Drug Administration ended 2024 with a quartet of notable drug approvals,...

Neumora Therapeutics, a well-funded biotechnology company, lost more than 80% of its value Thursday...

Happy New Year! We hope you had a restful holiday; If you took a...

David Epstein was ready to retire when an opportunity came along he couldn’t pass...

Swiss pharmaceutical company Novartis plans to close MorphoSys sites in the U.S. and Germany...

Vertex Pharmaceuticals lost more than $15 billion in value Thursday as new data on...

Dive Brief: Regeneron Pharmaceuticals intends to advance two blood-thinning drugs into Phase 3 testing...

KdT Ventures is launching a new biotechnology startup based on a drug it’s licensing...

A new type of obesity drug being developed by Novo Nordisk has fallen short...

Today, a brief rundown of news involving Ionis Pharmaceuticals and the Food and Drug...

An experimental drug for Parkinson’s disease that Roche has been developing for more than...

The Food and Drug Administration on Thursday reaffirmed its assessment that Mounjaro and Zepbound,...

Dive Brief: Merck & Co. has made its first big move in obesity treatment,...

Almost 15 years ago, in the midst of an opioid epidemic that would kill...

Namandjé Bumpus, the Food and Drug Administration’s second-in-command, will depart the regulator at the...

Dive Brief: An experimental drug co-developed by Teva and Sanofi met its main objectives...

Jazz Pharmaceuticals on Monday said it will begin searching for a successor to CEO...

Dive Brief: Novo Holdings can complete its $16.5 billion acquisition of contract drug manufacturer...

Research into women’s health has long gone underfunded in the U.S. But there’s some...

Dive Brief: AbbVie will pay $200 million to acquire privately held Nimble Therapeutics and...

Today, a brief rundown of news involving Gilead and Padlock Therapeutics, as well as...

A panel of experts convened by the Food and Drug Administration called for more...

In a rare move, the U.S. agency behind Medicare is warning insurers who provide...

The Food and Drug Administration has identified additional safety concerns associated with use of...

Dive Brief: Editas Medicine will lay off 180 employees, or about two-thirds of its...

Dive Brief: Shares of Q32 Bio lost two-thirds of their value Wednesday after the...

An experimental breast cancer drug developed by Eli Lilly met its main goal in...

Epigenetic editing startup Chroma Medicine is merging with Nvelop Therapeutics in a deal that...

The American Society of Hematology’s annual meeting continued Monday with important presentations and discussions...

Ally Schott felt lonely when she was diagnosed with endometriosis at the age of...

This weekend, thousands of researchers and physicians descended on San Diego for the American...

One year on from the landmark U.S. approval of two powerfully effective gene therapies...

Dive Brief: Atea Pharmaceuticals said Wednesday that its experimental combination regimen to treat the...

Today, a brief rundown of news involving Daiichi Sankyo, Agenus and Amgen, as well...

Dive Brief: BioAge Labs said it is terminating a mid-stage study of its obesity...

Eli Lilly will spend $3 billion to expand a manufacturing facility in Wisconsin it...

Robert F. Kennedy Jr., chosen by President-elect Donald Trump to be the next health...

Inside every human cell are thousands of snippets of genetic code that serve as...

Dive Brief: Atlas Venture said Thursday that it’s raised $450 million for its 14th...

Biotechnology startup Nuvig Therapeutics is the latest emerging immune drug developer to attract investors’...

Dewpoint Therapeutics, a young biotechnology company, could receive nearly half a billion dollars if...

Zepbound, an in-demand weight loss drug from Eli Lilly, helped people in a large...

Shares of Janux Therapeutics surged to record highs following the release of study results...

Today, a brief rundown of news involving Novocure and Merus, as well as updates...

The American Diabetes Association, a high-profile advocacy group, is warning against widespread use of...

Evolving technology has helped advance the field of gene therapy, and today, more and...

Brain drug developer Alector is laying off staff after one of its most advanced...

Swiss pharmaceutical giant Roche is spending around $1 billion to acquire a San Diego-based...

Roche’s long-running bet on a new kind of cancer immunotherapy has, after years of...

Today, a brief rundown of news involving Kronos Bio, Idorsia and PTC Therapeutics, as...

Dive Brief: Sarepta Therapeutics has turned to dealmaking to restock a drug pipeline analysts...

For drug companies, predicting how much money a product will make is a risky...

Dive Brief: Amgen on Tuesday said its weight loss drug MariTide helped people with...

The Biden administration on Tuesday proposed a rule that would allow Medicare and Medicaid...

Dive Brief: An experimental, muscle-preserving drug from Biohaven fell short of its goal in...

Dive Brief: Adding Merck & Co.’s new cardiovascular drug Winrevair to background therapy helped...

Howard Chang, a top biotechnology researcher and longtime professor at Stanford University, will join...

Retail pharmacy giants have been straining under the intense headwinds hitting the industry this...

Dive Brief: Lexicon Pharmaceuticals will lay off 60% of its workforce and eliminate its...

The Food and Drug Administration has approved a new medicine for a deadly genetic...

President-elect Donald Trump on Friday named Johns Hopkins University surgeon Marty Makary to lead...

Today, a brief rundown of news involving Halozyme and Neurogene, as well as updates...

Through a new deal, Novartis has added a handful of experimental gene therapies to...

Drug development is an expensive, risky endeavor. Biotechnology companies just starting out are many...

Pfizer on Wednesday said it will promote Chris Boshoff to chief scientific officer and...

Sage Therapeutics is shelving one of its most important experimental drugs, after a last-ditch...

Today, a brief rundown of news involving Astellas and Cytokinetics, as well as updates...

Dive Brief: An experimental under-the-skin injection of Merck & Co.’s cancer immunotherapy Keytruda showed...

Dive Brief: A single infusion of a CRISPR therapy developed by Intellia Therapeutics showed...

Dive Brief: Massachusetts-based Syndax Pharmaceuticals won Food and Drug Administration approval Friday for a new...

Merck & Co. has bought into the kind of drug that has emerged as...

In an unusual reversal, key drug regulators in Europe are now saying Leqembi, a...

Today, a brief rundown of news involving Evotec, Bluebird bio and the company formerly...

Market downturns take a toll. For many young biotechnology companies, the past few years...

Failure is more common than success for young biotechnology companies attempting to get a...

Trace Neuroscience, a freshly launched startup, is developing a type of genetic medicine it...

President-elect Donald Trump plans to nominate Robert F. Kennedy Jr. to lead the Department...

Dive Brief: PTC Therapeutics on Wednesday won Food and Drug Adminitration approval for Kebilidi,...

Dive Brief: Metsera, already a well-funded biotech startup, added another $215 million to its...

Today, a brief rundown of news involving Amgen and AstraZeneca, as well as updates...

Third Rock Ventures, the well-known backer of biotechnology companies, is leading a nine-figure fundraising...

Flagship Pioneering startup Vesalius Therapeutics has signed a deal with GSK, the companies announced...

Through a recent, nearly $9 billion acquisition, AbbVie surged to the front of a...

Dive Brief: The Food and Drug Administration on Friday approved a new cell therapy...

Acadia Pharmaceuticals agreed to sell a priority review voucher to an undisclosed buyer for...

Dive Brief: Sarepta Therapeutics is giving up on an experimental drug for Duchenne muscular...

Dive Brief: Athira Pharma, a small drugmaker focused on neuroscience, is looking into the...

Today, a brief rundown of news from AstraZeneca, Amgen and Jazz Pharmaceuticals, as well...

Public biotechnology company AlloVir has agreed to merge with the privately held Kalaris Therapeutics,...

With the U.S. presidential election decided, one name is suddenly circulating in healthcare: Robert...

Dive Brief: Moderna on Thursday reported third quarter sales of its COVID-19 vaccine that...

Donald Trump’s victory in the U.S. presidential election Tuesday means change is coming for...

Dive Brief: Dive Insight: Novo and Lilly are racing to build on their dominant...

Research into RNA interference, a Nobel Prize-winning technique to mute disease-causing gene mutations, has...

Dive Brief: A cancer cell therapy developed by Arcellx and Gilead Sciences helped reduce...

Sana Biotechnology will lay off staff and shift its research focus in the latest...

Neurogene, a gene therapy developer focused on rare neurological diseases, has secured $200 million...

As the third generation of PCR technology, digital PCR introduced powerful new capabilities to...

Michelle Tarver, the new leader of the Food and Drug Administration’s medical device center,...

California biotechnology startup Evommune has raised $115 million to advance a pair of medicines...

Dive Brief: Compass Pathways said it will lay off 30% of its workforce, narrow...

Today, a brief rundown of news from Regeneron Pharmaceuticals and Madrigal Pharmaceuticals, as well...

Novo Nordisk will seek regulatory approval of semaglutide, the key ingredient in its popular...

Dive Brief: Jade Biosciences, a privately held developer of immune disease drugs, will combine...

Dive Brief: Roche may seek an accelerated U.S. approval of its experimental Alzheimer’s disease...

Sales of GSK’s top-selling vaccines fell sharply during the third quarter amid lower demand,...

All doses of Novo Nordisk’s popular GLP-1 medicines Ozempic and Wegovy are available in...

Archon Biosciences came about as most startups do, the result of happenstance and good...

Sales of Pfizer’s new vaccine for respiratory syncytial virus were lower in the third...

Dive Brief: Novartis will pay $150 million to gain rights to “molecular glue degraders”...

AbbVie has agreed to acquire a young company with drugmaking technology from Johnson &...

Managing biospecimens is a critical, yet often overlooked, part of ensuring a clinical trial’s...

Dive Brief: Intellia Therapeutics on Thursday released detailed Phase 2 results from a study...

Dive Brief: Kivu Biosciences, a San Francisco-based biotechnology startup developing targeted drugs for cancer,...

A panel of advisers to the Centers for Disease Control and Prevention on Wednesday...

Today, a brief rundown of news from GSK and Amgen, as well as updates...

Sanofi reported a 25% boost in sales for its vaccines division during the third...

Septerna, a developer of medicines that target a ubiquitous family of proteins, on Thursday...

Lyell Immunopharma, a cell therapy developer that has struggled to match its high profile,...

Dive Brief: The Food and Drug Administration on Tuesday expanded the approval of Pfizer’s...

Alto Neuroscience, a young biotechnology company developing medicines for the brain, lost much of...

The Food and Drug Administration on Tuesday named Michelle Tarver as the permanent director...

Dive Brief: Novo Nordisk’s diabetes pill Rybelsus cut the risk of heart attacks, strokes...